Infinity Pharmaceuticals (INFI)
1.56
+0.03 +1.96%
NASDAQ
Sep 27, 16:59
Delayed 2m
USD
View All Key Stats
INFI Key Stats
| Income Statement | |
| Revenue (TTM) | 118.54M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.27 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 15.68M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 77.36M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.6505 |
| PE Ratio (TTM) | 5.778 |
| Price to Book Value | 0.6510 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -46.80M |
| Return on Equity (TTM) | 15.68% |
View All INFI News
INFI News
-
WireHeadlineTime (ET)
-
MT Newswires09/27 16:23
-
MT Newswires09/27 12:41
-
SA Breaking News09/27 09:16
-
MT Newswires09/26 17:55
-
MT Newswires09/26 17:52
-
MT Newswires09/26 17:30
-
PR Newswire09/26 17:15
-
Yahoo09/19 11:36
-
PR Newswire09/19 11:35
-
PR Newswire09/19 08:59
View All Events
INFI Events
| Date | Type | Description |
|---|---|---|
| 08/09/2016 16:30 EDT | Misc | Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2016 |
| 08/09/2016 | Earnings | Infinity Pharmaceuticals Inc Second Quarter Earnings in 2016 Release |
| 06/14/2016 08:30 EDT | Misc | Tesco PLC Annual General Meeting in 2016 |
| 05/04/2016 16:30 EDT | Misc | Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call in 2016 |
| 05/04/2016 | Earnings | Infinity Pharmaceuticals Inc First Quarter Earnings in 2016 Release |
| 02/23/2016 16:30 EST | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2015 |
| 02/23/2016 | Earnings | Infinity Pharmaceuticals Inc Fourth Quarter Earnings in 2015 Release |
| 11/05/2015 16:30 EST | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2015 |
| 11/05/2015 | Earnings | Infinity Pharmaceuticals Inc Third Quarter Earnings in 2015 Release |
INFI Fundamentals
Income Statement View Statement
INFI Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.infi.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: August 09, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its product candidate is duvelisib, also known as IPI-145, an oral inhibitor.
INFI Comparables
EditINFI Excel Add-In Codes
- Name: =YCI("INFI","name")
- Description: =YCI("INFI","description")
- Sector: =YCI("INFI","sector")
- Industry: =YCI("INFI","industry")
- Est. Current Fiscal Year End: =YCI("INFI","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other INFI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INFI Tweets Stocktwits
Advertisement